News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
491,226 Results
Type
Article (28383)
Company Profile (227)
Press Release (462616)
Section
Business (146117)
Career Advice (978)
Deals (25529)
Drug Delivery (60)
Drug Development (58516)
Employer Resources (100)
FDA (12477)
Job Trends (10866)
News (244411)
Policy (19868)
Tag
Academia (2028)
Alliances (42052)
Alzheimer's disease (935)
Antibody-drug conjugate (ADC) (86)
Approvals (12441)
Artificial intelligence (143)
Bankruptcy (179)
Best Places to Work (8932)
Biotechnology (171)
Breast cancer (96)
Cancer (879)
Cardiovascular disease (71)
Career advice (829)
Cell therapy (199)
Clinical research (46018)
Collaboration (360)
Compensation (84)
COVID-19 (2206)
C-suite (77)
Data (891)
Diabetes (92)
Diagnostics (5364)
Earnings (50532)
Employer resources (92)
Events (71869)
Executive appointments (241)
FDA (12871)
Funding (302)
Gene therapy (138)
GLP-1 (383)
Government (2445)
Healthcare (13998)
Infectious disease (2280)
Inflammatory bowel disease (99)
Interviews (147)
IPO (11029)
Job creations (2280)
Job search strategy (735)
Layoffs (221)
Legal (4110)
Lung cancer (147)
Manufacturing (143)
Medical device (11945)
Medtech (11950)
Mergers & acquisitions (14620)
Metabolic disorders (255)
Neuroscience (1128)
NextGen Class of 2024 (4807)
Non-profit (2680)
Northern California (1028)
Obesity (140)
Opinion (115)
Patents (77)
People (43143)
Phase I (14610)
Phase II (20115)
Phase III (15476)
Pipeline (351)
Postmarket research (1666)
Preclinical (6216)
Radiopharmaceuticals (206)
Rare diseases (155)
Real estate (4361)
Regulatory (14184)
Research institute (1900)
Resumes & cover letters (142)
Southern California (933)
Startups (3068)
United States (9824)
Vaccines (501)
Weight loss (85)
Date
Today (113)
Last 7 days (594)
Last 30 days (2792)
Last 365 days (26833)
2024 (24499)
2023 (30476)
2022 (40653)
2021 (43677)
2020 (41285)
2019 (34966)
2018 (26523)
2017 (25479)
2016 (24559)
2015 (28480)
2014 (21090)
2013 (17154)
2012 (18714)
2011 (19052)
2010 (17280)
Location
Africa (495)
Arizona (116)
Asia (31486)
Australia (5337)
California (2316)
Canada (859)
China (201)
Colorado (110)
Connecticut (105)
Europe (75600)
Florida (321)
Georgia (95)
Illinois (242)
Indiana (137)
Kansas (81)
Maryland (397)
Massachusetts (2133)
Michigan (149)
Minnesota (210)
New Jersey (743)
New York (689)
North Carolina (501)
Northern California (1028)
Ohio (92)
Pennsylvania (500)
South America (745)
Southern California (933)
Texas (305)
Washington State (306)
491,226 Results for "cambridge antibody technology group plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Hemogenyx Pharmaceuticals PLC Announces Operations Update - June 17, 2024
Hemogenyx Pharmaceuticals plc, the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its ongoing activities and progress.
June 17, 2024
·
4 min read
Vaccines
Bavarian Nordic’s Jynneos Elicits ‘Robust’ Mpox Antibody Response in Adolescents: Study
The mpox vaccine induced an antibody response in adolescents aged 12 to 17 years that matched that in adults, suggesting the shot can be used to protect the highly susceptible group.
October 17, 2024
·
2 min read
·
Tristan Manalac
Biotech Bay
AbTherx Opens Antibody Discovery Technologies Research Center
AbTherx, Inc., a biotechnology company with innovative technologies that enable and accelerate antibody discovery, announced the opening of its new antibody discovery technologies research center.
June 18, 2024
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
November 11, 2024
·
3 min read
Press Releases
Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer
October 15, 2024
·
3 min read
Press Releases
AbTherx and Gilead Expand Collaboration on Innovative Antibody Discovery Technologies
October 31, 2024
·
2 min read
Deals
30 Technology’s Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several Applications
30 Technology, the world leader in clinical nitric oxide generation technology for health care, announced that it has completed the sale of its antimicrobial nitric oxide platform in certain applications to Convatec Group Plc.
April 19, 2023
·
6 min read
Press Releases
Angle PLC Announces Half-year Report
September 26, 2024
·
8 min read
Press Releases
Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR
November 15, 2024
·
5 min read
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked first in overall corporate reputation among rare disease patient groups around the world who were familiar with the company.
August 23, 2023
·
4 min read
1 of 49,123
Next
